EcoDrugPlus

Ensembl ID : ENSACLG00000000745
Gene Symbol: -
1 Cross references
288 Possible Orthologues:

Ensembl ID : ENSACLG00000001066
Gene Symbol: -
Cross references: -
340 Possible Orthologues:

Ensembl ID : ENSACLG00000001136
Gene Symbol: -
Cross references: -
266 Possible Orthologues:

Ensembl ID : ENSACLG00000003971
Gene Symbol: -
Cross references: -
290 Possible Orthologues:

Ensembl ID : ENSACLG00000009670
Gene Symbol: -
Cross references: -
256 Possible Orthologues:

Ensembl ID : ENSACLG00000023458
Gene Symbol: -
Cross references: -
273 Possible Orthologues:

Ensembl ID : ENSACLG00000023544
Gene Symbol: -
Cross references: -
273 Possible Orthologues:

Ensembl ID : ENSACLG00000001604
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSACLG00000020826
Gene Symbol: -
Cross references: -
237 Possible Orthologues:

Ensembl ID : ENSACLG00000002295
Gene Symbol: -
Cross references: -
225 Possible Orthologues:

Ensembl ID : ENSACLG00000015748
Gene Symbol: -
Cross references: -
228 Possible Orthologues:

Ensembl ID : ENSACLG00000002548
Gene Symbol: -
Cross references: -
225 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).